# Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder
> **Product code: QFT** · Class II — Moderate Risk (510(k) clearance required) · Obstetrics/Gynecology · 21 CFR 882.5803
## Classification
- **FDA Product Code:** QFT
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 882.5803
- **Review panel:** NE
- **Medical specialty:** Obstetrics/Gynecology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

A digital therapy device for Attention Deficit Hyperactivity Disorder (ADHD) is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.

## Market data
- **Cleared 510(k) submissions:** 4
- **Registered establishments:** 1
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=QFT)
---
*AI Analytics · CC0 1.0*